Indian biotech firm develops first indigenous bi-specific 3rd generation CAR T cells for cancer… EP News Bureau Mar 19, 2025 Cellogen Therapeutics has secured $2 million in funding from NATCO Pharma and is preparing for clinical trials in collaboration…
Revolutionising cancer treatment: The promise of point-of-care CAR-T therapy Dr Prudwidhar S Jul 27, 2024 Dr Prudwidhar S, Country Medical Affairs Director, Miltenyi Biotec emphasises why successful implementation of CAR-T cell therapy…
CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData EP News Bureau Mar 13, 2021 Three leading companies racing to bring CRISPR therapies to the clinic are CRISPR Therapeutics, Intellia Therapeutics and Editas…
